Inbiome
PrivateLast Round
Series A
Apr 1, 2026
Total Funding Raised
$16M
Momentum Score
75 /100
Company Overview
Inbiome is a biotechnology company that has developed a patented Molecular Culture technology, which uses machine learning and chemistry for rapid bacterial diagnostics and microbiome analysis.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Precision Medicine, Defense Tech
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Inbiome Comps
Public and private peers based on sector, stage, and business model.
Inbiome Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 1, 2026 | ||||
| Grant | Jan 11, 2023 |
Inbiome Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council | Grant |
| Slingshot Ventures | Series A |
| NATO Innovation Fund | Series A |
| Voima Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 1, 2026
$16M round completed.
- Jan 22, 2026
Monthly visitors grew 789% MoM, reaching 7.5K.
Inbiome Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Inbiome's valuation, stock price, and market status.
